American Portfolios Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $1.41M | Sell |
25,775
-1,525
| -6% | -$83.6K | 0.06% | 319 |
|
|
2022
Q2 | $1.8M | Sell |
27,300
-34
| -0.1% | -$2.25K | 0.07% | 269 |
|
|
2022
Q1 | $1.81M | Buy |
27,334
+4,731
| +21% | +$314K | 0.06% | 307 |
|
|
2021
Q4 | $1.32M | Buy |
22,603
+4,446
| +24% | +$259K | 0.04% | 398 |
|
|
2021
Q3 | $1.09M | Buy |
18,157
+4,335
| +31% | +$260K | 0.04% | 429 |
|
|
2021
Q2 | $828K | Buy |
13,822
+577
| +4% | +$34.6K | 0.03% | 520 |
|
|
2021
Q1 | $659K | Sell |
13,245
-1,899
| -13% | -$94.4K | 0.03% | 552 |
|
|
2020
Q4 | $757K | Sell |
15,144
-4,750
| -24% | -$237K | 0.04% | 425 |
|
|
2020
Q3 | $1.09M | Sell |
19,894
-466
| -2% | -$25.5K | 0.06% | 273 |
|
|
2020
Q2 | $1.08M | Buy |
20,360
+8,098
| +66% | +$428K | 0.07% | 260 |
|
|
2020
Q1 | $548K | Sell |
12,262
-1,512
| -11% | -$67.5K | 0.05% | 345 |
|
|
2019
Q4 | $687K | Buy |
13,774
+91
| +0.7% | +$4.54K | 0.05% | 337 |
|
|
2019
Q3 | $610K | Sell |
13,683
-786
| -5% | -$35K | 0.05% | 345 |
|
|
2019
Q2 | $597K | Sell |
14,469
-272
| -2% | -$11.2K | 0.05% | 342 |
|
|
2019
Q1 | $596K | Buy |
14,741
+3,486
| +31% | +$141K | 0.06% | 323 |
|
|
2018
Q4 | $427K | Sell |
11,255
-988
| -8% | -$37.5K | 0.05% | 313 |
|
|
2018
Q3 | $484K | Sell |
12,243
-286
| -2% | -$11.3K | 0.06% | 322 |
|
|
2018
Q2 | $440K | Sell |
12,529
-88
| -0.7% | -$3.09K | 0.06% | 312 |
|
|
2018
Q1 | $441K | Buy |
12,617
+1,712
| +16% | +$59.9K | 0.07% | 287 |
|
|
2017
Q4 | $378K | Buy |
+10,905
| New | +$378K | 0.06% | 321 |
|